Drug Trial Radar · NCT04262856
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer
Last checked: Nov 19, 2026Latest source record: Jun 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
151
Actual
Start
May 28, 2020
Primary completion
Jul 9, 2025
Study completion Jul 9, 2025
Sponsor
- Lead sponsor
- Arcus Biosciences, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Gilead Sciences
- First posted
- Feb 10, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase 2 open-label study will evaluate the safety and efficacy of zimberelimab (AB122) monotherapy, domvanalimab (AB154) in combination with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non-small cell lung cancer.
Conditions
- Non Small Cell Lung Cancer
- Nonsquamous Non Small Cell Lung Cancer
- Squamous Non Small Cell Lung Cancer
- Lung Cancer
Interventions
DomvanalimabDrug
Domvanalimab is a humanized monoclonal antibody targeting human TIGIT
EtrumadenantDrug
Etrumadenant is an A2aR and A2bR antagonist
ZimberelimabDrug
Zimberelimab is a fully human anti-PD-1 monoclonal antibody
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response rate (ORR)Time frame: From randomization until the first documentation of disease progression or death from any cause, whichever occurs first (up to approximately 3-5 years)
- Progression-free survival (PFS)Time frame: From randomization until the first documentation of disease progression or death from any cause, whichever occurs first (up to approximately 3-5 years)
Locations
44 sites in 7 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Innovative Clinical Research Institute (ICRI)
Whittier, California
Florida Cancer Specialists
Englewood, Florida
Florida Cancer Specialists
Gainesville, Florida
Florida Cancer Specialists - Panhandle
Tallahassee, Florida
Florida Cancer Specialists - East
West Palm Beach, Florida
Baptist Health Lexington
Lexington, Kentucky
Norton Cancer Institute
Louisville, Kentucky
Ochsner Clinic Foundation
New Orleans, Louisiana
The Valley Hospital - Valley Health System - The Robert and Audrey Luckow Pavilion
Ridgewood, New Jersey
Clinical Research Alliance
Lake Success, New York
Northwell Health Cancer Institute
Lake Success, New York
Wake Forest Baptist Health
Winston-Salem, North Carolina
Allegheny General Hospital (AGH)-Alleghney Singer Research Institute
Pittsburgh, Pennsylvania
Sarah Cannon Research Institute
Nashville, Tennessee
The Center For Cancer And Blood Disorders (Texas Cancer Care)
Fort Worth, Texas
Millennium Oncology
Houston, Texas
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
Blacksburg, Virginia
Virginia Cancer Specialists
Fairfax, Virginia
Border Medical Oncology
Albury, Australia
Coffs Harbour Health Campus
Coffs Harbour, Australia
Adelaide Cancer Centre
Elizabeth Vale, Australia
Shoalhaven Cancer Care Centre
Nowra, Australia
McGill University Health Centre (MUHC) - The Montreal Children's Hospital (MCH)
Montreal, Canada
Hong Kong United Oncology Centre
Hong Kong, Hong Kong
Queen Elizabeth Hospital (Hong Kong)
Hong Kong, Hong Kong
Curie Oncology
Singapore, Singapore
Kosin University Gospel Hospital
Busan, South Korea
Chungbuk National University Hospital (CBNUH)
Cheongju-si, South Korea
Chonnam University Hospital
Hwasun, South Korea
Gachon University Gil Medical Center
Incheon, South Korea
Chonbuk National University Hospital
Jeonju, South Korea
Seoul National University Bundang Hospital
Seongnam-si, South Korea
Asan Medical Center
Seoul, South Korea
Kangbuk Samsung Hospital
Seoul, South Korea
Korea University Anam Hospital
Seoul, South Korea
St Vincent Hospital of the Catholic University of Korea
Suwon, South Korea
Catholic University of Korea, Uijeongbu St. Mary's Hospital
Uijeongbu-si, South Korea
Taipei Medical University - Shuang Ho Hospital
New Taipei City, Taiwan
Chi Mei Hospital
Tainan, Taiwan
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.